
Eli Lilly and Company has broken ground on a new $5 billion manufacturing facility just west of Richmond, Virginia, USA – one of 10 new US manufacturing sites announced since 2020 and one of five among them that will produce active pharmaceutical ingredients (API).
As part of the company’s more than $50 billion push to expand medicine production in the US, the Richmond site will be Lilly’s first to produce both API and finished medicines in a fully integrated facility, with dedicated API capacity for bioconjugate and large-molecule medicines.
The facility will produce antibody-drug conjugates (ADCs), targeted cancer treatments designed to combine the precision of antibodies with potent cytotoxic medicines to attack diseased cells directly while limiting exposure to healthy tissue. ADCs are also being explored for autoimmune diseases and other conditions.
Building a talent pipeline in Richmond Making advanced medicines in the US requires a highly skilled workforce. Lilly is building that workforce in Virginia, offering long-term careers where people can grow close to home. Lilly has committed $40 million to support the Virginia Center for Advanced Pharmaceutical Manufacturing, a statewide network of industry, government, and higher education partners that will prepare Virginians for those careers. The network will include a pilot-scale, hands-on training centre in Goochland County, with a targeted opening in 2028.
By pairing a highly skilled workforce with advanced technologies and specialised manufacturing, the Richmond site will help support a reliable supply of safe, high-quality medicines. It will use state-of-the-art technologies, including machine learning, AI, digitally integrated systems and advanced data analytics, to drive right-first-time execution, with digital automation embedded throughout the site to streamline operations.
The Richmond facility will be built and operated to the highest standards for safety, quality and environmental stewardship, and Lilly is committed to being a good neighbour in Goochland County and a trusted partner across Virginia. The site is targeting a Leadership in Energy and Environmental Design (LEED) Gold certification, demonstrating Lilly’s focus on sustainable performance as it expands advanced manufacturing in the US.


